Company Filing History:
Years Active: 1976
Title: The Innovations of Philip E. Shaw
Introduction
Philip E. Shaw is a notable inventor based in Winter Haven, FL (US). He has made significant contributions to the field of chemistry, particularly in the development of cardiotonic compounds. With a total of 2 patents, his work has implications in medicinal chemistry and pharmacology.
Latest Patents
Shaw's latest patents include innovative methods for preparing polyhydrophenanthrene derivatives. One of his patents describes the preparation of alkyl polyhydro-2-phenanthrylideneacetates through the interaction of 2-oxopolyhydrophenanthrenes with tri-lower-alkyl α-phosphono-lower-alkanoates. These compounds are then hydrolyzed to yield free acids, which are subsequently reesterified with tertiary-amino-lower-alkanols to produce basic esters exhibiting cardiotonic activity. Another patent focuses on the synthesis of polyhydro-2-phenanthrylideneacetic acids and their esters, utilizing similar chemical interactions to achieve the desired cardiotonic properties.
Career Highlights
Philip E. Shaw has been associated with Sterling Drug Inc., where he has contributed to various research projects and innovations. His work has been instrumental in advancing the understanding of cardiotonic agents and their applications in medicine.
Collaborations
Throughout his career, Shaw has collaborated with notable colleagues, including Sol J. Daum and Robert L. Clarke. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical field.
Conclusion
Philip E. Shaw's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new medicinal compounds, showcasing the importance of innovation in healthcare.